ArticleFrontiers in medicine2023

FAIL-T (AFP, AST, tumor sIze, ALT, and Tumor number): a model to predict intermediate-stage HCC patients who are not good candidates for TACE.

Apichat Kaewdech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.